Image

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

Recruiting
21-75 years
All
Phase N/A

Powered by AI

Overview

The study aims to evaluate the feasibility of using Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) as a tool to decreasing distress and cigarette smoking. 46 participants currently smoking cigarettes, and seeking to decrease cigarette use will be recruited.

Eligibility

Inclusion Criteria:

  • 21-75 years old
  • smoke ≥10 cigarettes per day
  • mild to moderate distress (K10 scores 10-35)
  • access to a reliable internet connection
  • all prescription medications stable for ≥ 1 month prior to enrollment and throughout the trial, and approved by the Study Physician

Exclusion Criteria:

  • Current suicidal ideation
  • Current use of smoking cessation medication (e.g., varenicline)
  • Current use of inhaled products (other than cigarettes) which may influence exhaled carbon monoxide measures (e.g. smoking cannabis, vaping)
  • History of seizure disorder, recent (<5 years) seizure history, cerebrovascular accident, neurodegenerative disease, or traumatic brain injury
  • Currently receiving chemotherapy or radiation
  • Presence of metal objects in the head/neck
  • Any skin disorder or skin sensitive area near stimulation locations

Study details
    Smoking Cessation

NCT05460676

Wake Forest University Health Sciences

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.